查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529619

基于水凝胶的 DDS（药物传输系统）市场规模、份额和趋势分析报告：按聚合物来源、传输途径、地区和细分市场预测，2024-2030 年

Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Delivery Route, By Region, And Segment Forecast, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

基于水凝胶的 DDS（药物传输系统）市场成长与趋势：

Grand View Research最新报告显示，到2030年，全球水凝胶DDS市场规模预计将达到117.7亿美元。

预计2024年至2030年该市场将以6.7%的复合年增长率扩张。水凝胶有助于在空间和时间上控制所掺入药物的释放。因此，许多治疗领域对控制释放药物输送系统的需求迅速成长是预测期内推动市场成长的主要因素。

以水凝胶为基础的 DDS 将治疗剂直接且可持续地递送至目标部位。这可以带来有益的结果，例如提高疗效、减少副作用以及减少患者和药物製造商的剂量。基于水凝胶的 DDS 很有吸引力，可用于许多医学领域，包括肿瘤学、疼痛管理、免疫学、心臟病学和伤口管理。

水凝胶独特的物理性质引起了人们对其在药物传输方面的应用的兴趣。水凝胶的孔隙率和载药能力可以透过调节交联密度来调节。这有助于保护大药物分子免于降解，并延长半衰期。已经对使用水凝胶系统口服胰岛素进行了许多研究。此类创新预计将成为糖尿病治疗市场的颠覆性技术，因为注射胰岛素经常出现患者依从性问题。

针对基于水凝胶的 DDS 的大量临床研究正在进行中，并且各种水凝胶技术已获得生物医学应用的监管核准。然而，缺乏明确的监管指南、化学问题、复杂的製造和控制参数以及实际适应性等技术挑战仍然是成功给药的主要障碍。例如，水凝胶的生产很复杂，并且根据水凝胶系统的不同而有很大差异。

基于水凝胶的 DDS 市场报告亮点：

  • 根据聚合物来源，合成细分市场在 2023 年占据最大市场占有率。
  • 由于刺激响应水凝胶技术的发展，预计混合市场将在预测期内呈现最快的成长率。
  • 与天然水凝胶相比，合成水凝胶由于其高载药量和改进的机械强度，预计在预测期内将出现快速增长。
  • 根据交付路线，眼部细分市场在 2023 年占据最大的收益占有率。
  • 由于正在进行的临床和临床前试验数量不断增加，预计皮下细分市场将在预测期内实现健康成长。
  • 由于北美地区有主要企业在研究和开发基于水凝胶的特定 DDS，因此北美地区占据了该市场的最大收益占有率。
  • 由于患者人数众多、医疗基础设施改善以及对尖端治疗的需求激增，预计亚太地区在预测期内将以最快的速度成长市场。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章基于水凝胶的 DDS 市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 基于水凝胶的 DDS 市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 基于水凝胶的DDS市场：基于聚合物的估算与趋势分析

  • 细分仪表板
  • 基于水凝胶的 DDS 市场：2023 年和 2030 年聚合物衍生波动分析
  • 自然
  • 合成
  • 混合

第五章 基于水凝胶的 DDS 市场：递送路线估计和趋势分析

  • 细分仪表板
  • 基于水凝胶的 DDS 市场：2023 年和 2030 年输送路线波动分析
  • 皮下的
  • 眼睛
  • 口腔
  • 局部的
  • 其他的

第六章基于水凝胶的DDS市场：区域估计和趋势分析

  • 2023 年和 2030 年按地区分類的水凝胶 DDS市场占有率，十亿美元
  • 北美洲
    • 2018-2030 年北美基于水凝胶的 DDS 市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030 年欧洲基于水凝胶的 DDS 市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区基于水凝胶的 DDS 市场估计和预测，2018-2030 年
    • 中国
    • 日本
    • 印度
    • 韩国
  • 拉丁美洲
    • 拉丁美洲基于水凝胶的 DDS 市场估计和预测，2018-2030 年
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030 年中东和非洲基于水凝胶的 DDS 市场估计和预测
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 南非

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • GE HealthCare
    • Siemens Healthineers AG
    • Medtronic
    • Aramark
    • Koninklijke Philips NV
    • B. Braun SE
    • AlphaSource Group
    • Althea Group
简介目录
Product Code: GVR-4-68038-285-3

Hydrogel-based Drug Delivery System Market Growth & Trends:

The global hydrogel-based drug delivery system market size is anticipated to reach USD 11.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2024 to 2030. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.

Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.

The unique physical properties of hydrogel attract their interest in use for drug delivery applications. The porosity and drug loading capacity of hydrogels can be adjusted by modifying the density of cross-linking. This helps them to protect liable large drug molecules from degradation increasing the half-life. Many research studies have been carried out to examining the delivery of insulin orally using hydrogel systems. As patient compliance issues are frequently reported with injectable insulins such innovation is expected to be a disruptive technology in the diabetes care market.

There are numerous clinical studies underway specific to hydrogel-based drug delivery systems and various hydrogel technologies have already received regulatory approval for biomedical application. However, the technological challenges including the absence of defined regulatory guidelines, chemistry, complex manufacturing and control paraments, and practical adaptability are major roadblocks in the successful implementation in drug delivery use. For instance, the fabrication of hydrogel is complex and varies significantly depending upon the hydrogel systems.

Hydrogel-based Drug Delivery System Market Report Highlights:

  • Based on polymer origin, the synthetic segment held the largest proportion of market share in 2023
  • The hybrid segment is expected to witness the fastest growth rate over the forecast period owing to the development of stimuli-responsive hydrogel technology
  • The synthetic segment is anticipated to grow fast over the forecast period compared to natural hydrogels due to their high drug loading capacity and improved mechanical strength
  • Based on delivery route, the ocular segment accounted for the largest revenue share in 2023
  • The subcutaneous segment is expected to grow at a healthy rate over the forecast period owing to the increasing number of clinical and pre-clinical studies carried out
  • North America holds the largest revenue share in this market due to the presence of key companies in the region doing R&D on specific hydrogel-based drug delivery systems
  • In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to large patient base, improving healthcare infrastructure, and surging demand for modern therapies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Hydrogel-based Drug Delivery System Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Hydrogel-based Drug Delivery System Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Hydrogel-based Drug Delivery System Market: Polymer Origin Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Hydrogel-based Drug Delivery System Market: Polymer Origin Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Natural
    • 4.3.1. Natural Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Synthetic
    • 4.4.1. Synthetic Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Hybrid
    • 4.5.1. Hybrid Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Hydrogel-based Drug Delivery System Market: Delivery Route Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Hydrogel-based Drug Delivery System Market: Delivery Route Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Subcutaneous
    • 5.3.1. Subcutaneous delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Ocular
    • 5.4.1. Ocular delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Oral Cavity
    • 5.5.1. Oral Cavity delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Topical
    • 5.6.1. Topical delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Other delivery routes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hydrogel-based Drug Delivery System Market: Regional Estimates & Trend Analysis

  • 6.1. Hydrogel-based Drug Delivery System Market Share, By Region, 2023 & 2030, USD Billion
  • 6.2. North America
    • 6.2.1. North America Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. Kuwait
      • 6.6.4.1. Kuwait Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Africa
      • 6.6.5.1. South Africa Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. GE HealthCare
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Siemens Healthineers AG
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Medtronic
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Aramark
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Koninklijke Philips N.V.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. B. Braun SE
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. AlphaSource Group
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Althea Group
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives